2019 BioTech Leadership 
Health Populi
MAY 20, 2021
Hospitals’ fall from 70% to 63% between 2018 and 2019. Consumer health’s fall from 63% in 2019 to 51% in 2020. Health insurance’s decline from 55% in 2017 to 46% in 2018, recovering in 2019 then falling again to a low of 43% this year in the 2021 Barometer. The vaccination-willingness gap in the U.S.
Health Populi
MARCH 19, 2019
Key issues facing the industry in 2019 and into the next few years range from regulation of dietary supplements and the role of CBD in self-care, the omni-channel consumer, ecommerce vs. bricks-and-mortar, trust, and wrestling with consumer privacy. Consumer health went opposite, up 7 points, biotech up 3, insurance up 8, pharma up 6.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Digital Health Global
MARCH 1, 2023
With over 20 years of experience in pharmaceutical, medtech, digital health, biotech and diagnosis, Julie’s leadership approach focuses on inspiring teams to deliver sustainable growth in challenging markets and healthcare environments. We are pleased to welcome Julie Xing to our Board of Directors.
Lloyd Price
SEPTEMBER 30, 2024
Recursion Pharmaceuticals: A biotech company using AI to discover new drug candidates. Healthcare Technology Thought Leadership from Nelson Advisors – Market Insights, Analysis & Predictions. Healthcare Technology Thought Leadership from Nelson Advisors – Market Insights, Analysis & Predictions. Why Healthcare?
mHealth Insight
FEBRUARY 21, 2019
Best Mobile Innovation for Health and BioTech c. ACCIO-IWC Innovation World Cup Pitch & Award Ceremony 2019 BARCELONA. Centre for Information Policy Leadership. Date & Time. Monday, 25 Feb. 10:00 – 10:30. Description. Fourth Industrial Revolution a. Best Mobile Innovation for Enterprise b. Partner Programmes.
Lloyd Price
FEBRUARY 14, 2019
After years of quiet growth, backed by patient investors, however, 2019 is likely to be the year Ada starts making headlines. As a result, more and more investors are paying attention to the health sector which, due to its complexity, has traditionally been left to biotech or medical devices investors.
Expert insights. Personalized for you.
317 
Let's personalize your content